Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models

详细信息	查看全文 | 推荐本文 |

• 作者：Takeshi Tanaka ; Takako Furukawa ; Shigeharu Fujieda ; Shingo Kasamatsu ; Yoshiharu Yonekura and Yasuhisa Fujibayashi
• 刊名：Nuclear Medicine and Biology
• 出版年：2006
• 期刊代码：43_09698051
• 类别：ph
• 出版时间：August 2006
• 卷：33
• 期：6
• 页码：743-750
• 文件大小：4740 K

摘要

Background

We studied the regional characteristics within tumor masses using PET tracers and immunohistochemical methods.

Methods

The intratumoral distribution of ⁶⁴Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([⁶⁴Cu]Cu-ATSM) and [¹⁸F] 2-fluoro-2-deoxyglucose (¹⁸F]FDG) in mice with tumors of four different origins (LLC1, Meth-A, B16 and colon26) was compared with the immunohistochemical staining of proliferating cells (Ki67), blood vessels (CD34 or von Willebrand factor), and apoptotic cells (terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling method).

Results

With all cell lines, [⁶⁴Cu]Cu-ATSM and [¹⁸F]FDG were distributed with different gradation in the tumor mass. The immunohistochemical study demonstrated that the high [⁶⁴Cu]Cu-ATSM uptake regions were hypovascular and consisted of tumor cells arrested in the cell cycle, whereas the high [¹⁸F]FDG uptake regions were hypervascular and consisted of proliferating cells.

Conclusion

In our study, it was revealed that one tumor mass contained two regions with different characteristics, which could be distinguished by [⁶⁴Cu]Cu-ATSM and [¹⁸F]FDG. Because hypoxia and cell cycle arrest are critical factors to reduce tumor sensitivity to radiation and conventional chemotherapy, regions with such characteristics should be treated intensively as one of the primary targets. [⁶⁴Cu]Cu-ATSM, which can delineate hypoxic and cell cycle-arrested regions in tumors, may provide valuable information for cancer treatment as well as possibly for treating such regions directly as an internal radiotherapy reagent.